HealthTech

Understanding Artificial Intelligence in Medical Devices

In this webinar series, learn from AI leaders about Healthtech AI, the challenges and strategy, use cases and how the health sector is gaining value from AI.

Learn more

In this webinar series, learn from AI leaders about Healthtech AI, the challenges and strategy, use cases and how the health sector is gaining value from AI.

Dr Abtin Rad – Understanding Artificial Intelligence in medical devices.

Dr. Abtin Rad is Global Director of Functional Safety, Software and Digitization at TÜV SÜD. He is also the Cybersecurity and Artificial Intelligence Specialist for medical devices and medical software at TÜV SÜD. Dr. Abtin Rad is professional in biomedical and electrical Engineer with a focus on software, cyber security and artificial intelligence. In this webinar, Dr. Rad explores understanding Artificial Intelligence in medical devices with a basic introduction into the technology and risk associated with its application.

Today, we are talking about AI in HealthTech where we will be delving into AI and the world of health care. A great opportunity to understand the challenges and strategies current health tech companies are facing and a chance to see use cases that are currently being used in these companies and how AI is implemented in the health sector. Last but certainly not the least we will be looking into how the health sector can gain value from this AI!

HealthTech

Successfully Deploying AI in Medicine

Matthew Squire from Fuzzy Labs | AI Tech North Summit 2020

Learn more

Matthew Squire from Fuzzy Labs | AI Tech North Summit 2020

Matt has spent his career building large-scale distributed and reactive software in many domains including advertising, medtech, biometrics, and IoT applications. Since co-founding Fuzzy Labs Matt has focused on helping businesses adopt AI-driven solutions, as well as leading R&D projects in smart wearables.

HealthTech

NHS AI Lab – One Year On

Peter Williams from NHSX | AI Tech North Summit 2020 | Peter is the Head of Tech Policy at NHSX

Learn more

Peter Williams from NHSX | AI Tech North Summit 2020 | Peter is the Head of Tech Policy at NHSX

HealthTech

Drug Discovery and Diagnostics Using AI

Prof. John Overington from Medicines Discovery Catapult | AI Tech North Summit 2020

Learn more

Prof. John Overington from Medicines Discovery Catapult | AI Tech North Summit 2020

In 2017 John joined the Medicines Discovery Catapult as CIO, where he leads the development and application of informatics approaches to promote and support innovative, fast-to-patient drug discovery in the UK through collaborative projects across the applied R&D community. John joined from technology company BenevolentAI, where he was involved in the development of novel data extraction and integration strategies, integrating deep learning and other Artificial Intelligence approaches to drug target validation and drug optimisation. Prior to this, John worked for Inpharmatica, where he led the development of a series of computational and data platforms to improve drug discovery, including the medicinal chemistry database StARLite. In 2008 he was central to the transfer of this database to the EMBL-EBI, where the successor is now known as the ChEMBL. More recently, the work extended into large-scale patent informatics with the Open patent database SureChEMBL. John, who has a degree in Chemistry from the University of Bath and a PhD from Birkbeck College, London, has also worked at Pfizer – first as a computational chemist and then leading a multidisciplinary group combining rational drug design with structural biology. He has also held a postdoctoral position at the Imperial Cancer Research Fund (now part of CRUK). John is a visiting professor at UCL and the University of Manchester.